David Lee Holtzman MD
Assistant Professor, Infectious Diseases
801 Massachusetts Ave | (617) 638-8052dlh@bu.edu
Sections
Infectious Diseases
Biography
I am a US board-certified infectious diseases specialist, internist, and pediatrician with extensive clinical, research, and public health experience with a focus on HIV and TB in Africa. My primary career goal is to improve health and health systems for underserved populations through research, clinical care, education, and project implementation. My research interests are to better understand the epidemiology of TB and other infectious diseases in resource-limited settings and identify interventions to address them.
Education
Medicine, MD, University of Pennsylvania School of Medicine
Infectious Disease Epidemiology, MSc, London School of Hygiene & Tropical Medicine
Biological Sciences, BA, University of Pennsylvania
Publications
Crowley BM, Boshoff HI, Boving A, Tan VY, Zhu J, Hoyt F, Miller RR, Ehrhart J, Boyce CW, Young K, Nantermet PG, Su J, Yang L, Painter RE, Corcoran EB, Hoar JL, Oh S, Holtzman DL, Levi M, Anderson A, Otieno MA, Zimmerman M, Kaya F, Massoudi LM, Ramey ME, Bauman AA, Lenaerts AJ, Roberston GT, Dartois V, Wells CD, Barry CE, Olsen DB. Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis. Nat Med. 2026 Feb; 32(2):553-560. PMID: 41530381.
Published on 9/1/2021Asfaw MT, Holtzman DL, Kwan GF, Oyewusi LT, Mitnick CD, Seung KJ. INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES. Afr J Infect Dis. 2021; 15(2 Suppl):38-41. PMID: 34595385.
Published on 1/30/2015Sander LD, Holtzman D, Pauly M, Cohn J. Time savings--realized and potential--and fair compensation for community health workers in Kenyan health facilities: a mixed-methods approach. Hum Resour Health. 2015 Jan 30; 13:6. PMID: 25637089.
Published on 7/12/2012Gaieski DF, Goldman JD, Holtzman DL, Shoff WH, Shepherd SM, Mehta N, Goyal M. Algid malaria treated with early goal-directed therapy. Am J Emerg Med. 2013 Jan; 31(1):263.e5-10. PMID: 22795409.